FLUIDDA is active in the field of Functional Respiratory Imaging (FRI) research and development. The company’s proprietary FRI technology offers pharmaceutical companies and healthcare providers a unique entry point into drug development strategies for patients suffering from respiratory diseases such as Idiopathic Pulmonary Fibrosis. Implementation of FRI in the clinical practice creates significant added value to the current healthcare standard in the respiratory field.
Biocellvia performs bespoke digital image analysis for preclinical disease models. Our individual specialised programs are proprietary and customized for each pathology, with internal team of biologists and software developers. The quantitative image analysis is completely automated, precise, and reproducible. The Biocellvia digital method has been fully validated and integrated by biotech and pharmaceutical companies worldwide. Notable collaboration in IPF with Boehringer Ingelheim.
Aragen Bioscience is a leading contract research organization, focused on accelerating antibody and other large-molecule pre-clinical development. Our integrated service offerings include: cell line development, protein expression, protein purification, process development, cell-based assays, biophysical assays, and in vivo models of disease. We are based in the San Francisco Bay Area.